CHINA PHARMA HOLDINGS, INC.

CPHI · NYSE · SIC 2834: Pharmaceutical Preparations
189
SEC Filings

Business Summary

China Pharma Holdings, Inc. is a Nevada holding company operating through its wholly owned subsidiary Hainan Helpson Medical and Biotechnology Co., Ltd. (Helpson) in China. Helpson develops, manufactures, and markets pharmaceutical products including dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. As of December 31, 2025, the company holds rights to manufacture 19 pharmaceutical products across basic generic drugs, first-to-market generic drugs, and Modern Traditional Chinese Medicines (TCMs), sold primarily on a prescription basis in the PRC.

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCPHIdiscussed_in_filing Cybersecurity
topic_mentionCPHIdiscussed_in_filing Trusted Computing
topic_mentionCPHIdiscussed_in_filing Blockchain & Crypto
topic_mentionCPHIdiscussed_in_filing Supply Chain
topic_mentionCPHIdiscussed_in_filing Regulation
topic_mentionCPHIdiscussed_in_filing Enterprise
topic_mentionCPHIdiscussed_in_filing Healthcare & Bio
topic_mentionCPHIdiscussed_in_filing Platform & Ecosystem
topic_mentionCPHIdiscussed_in_filing Networking
topic_mentionCPHIdiscussed_in_filing Sovereign & Government
topic_mentionCPHIdiscussed_in_filing Cybersecurity
topic_mentionCPHIdiscussed_in_filing Trusted Computing
topic_mentionCPHIdiscussed_in_filing Blockchain & Crypto
topic_mentionCPHIdiscussed_in_filing Supply Chain
topic_mentionCPHIdiscussed_in_filing Regulation
topic_mentionCPHIdiscussed_in_filing Enterprise
topic_mentionCPHIdiscussed_in_filing Healthcare & Bio
topic_mentionCPHIdiscussed_in_filing Platform & Ecosystem
topic_mentionCPHIdiscussed_in_filing Networking
topic_mentionCPHIdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-012025-12-310001213900-26-038521EDGAR62K words
2025-03-312024-12-310001213900-25-026280EDGAR—
2024-04-012023-12-310001213900-24-028731EDGAR—
2023-03-302022-12-310001213900-23-024710EDGAR—
2022-03-302021-12-310001213900-22-016151EDGAR—
2021-03-262020-12-310001213900-21-017981EDGAR—
2020-03-302019-12-310001213900-20-008020EDGAR—
2019-03-282018-12-310001213900-19-005094EDGAR—
2018-04-022017-12-310001213900-18-003895EDGAR—
2017-03-312016-12-310001010549-17-000112EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-109203EDGAR19K words
2025-08-142025-06-300001213900-25-076642EDGAR—
2025-05-142025-03-310001213900-25-043334EDGAR—
2024-11-132024-09-300001213900-24-097461EDGAR—
2024-08-142024-06-300001213900-24-068984EDGAR—
2024-05-152024-03-310001213900-24-043591EDGAR—
2023-11-132023-09-300001213900-23-086100EDGAR—
2023-08-142023-06-300001213900-23-066936EDGAR—
2023-05-122023-03-310001213900-23-039007EDGAR—
2022-11-142022-09-300001213900-22-072200EDGAR—
2022-08-112022-06-300001213900-22-046859EDGAR—
2022-05-122022-03-310001213900-22-025938EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001213900-26-023022EDGAR1K words
2026-02-100001213900-26-014338EDGAR—
2026-01-060001213900-26-001785EDGAR—
2025-12-230001213900-25-125299EDGAR—
2025-12-100001213900-25-120129EDGAR—
2025-04-040001213900-25-029000EDGAR—
2024-12-260001213900-24-112685EDGAR—
2024-12-260001213900-24-112658EDGAR—
2024-12-130001213900-24-108617EDGAR—
2024-05-300001213900-24-047965EDGAR—

189 total filings indexed. 157 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

prescription-pharmaceutical-market-in-china over-the-counter-(otc)-pharmacy-market-in-china hospital-market-in-china primary-healthcare-institution-market-in-china traditional-chinese-medicine-(tcm)-market generic-drug-market-in-china good-manufacturing-practices-for-pharmaceutical-products-(2010-revised-version,-year-2011-gmp-standards) drug-administration-law-(new-law,-effective-december-1,-2019) nmpa-(national-medical-products-administration)-regulations gsp-certification drug-supply-license

Company Identity

CIK0001106644
TickerCPHI
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersHaikou, Hainan Province

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 37b5063e917b7cf10eafd442247bae38dea720690091149ea2603fe6eceaa284
parent: d28dd5ab7ba54e2a628bb09015849962b762da637a3e3a9f397e8c91b8ccebdf
content hash: 420c853ce32ecd4c8559a71e311018ac25a92247df98f11f9ac8553b603d57b2
signed: 2026-04-13T04:44:27.494Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf